These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Hyperdynamic circulation and the insulin resistance syndrome ("syndrome X"). Stern MP; Morales PA; Haffner SM; Valdez RA Hypertension; 1992 Dec; 20(6):802-8. PubMed ID: 1452296 [TBL] [Abstract][Full Text] [Related]
65. Basic approach to managing hyperglycemia for the nonendocrinologist. Deeg MA Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842 [TBL] [Abstract][Full Text] [Related]
66. Insulin resistance: implications for Maori. Joseph N Pac Health Dialog; 2000 Mar; 7(1):122-3. PubMed ID: 11709874 [No Abstract] [Full Text] [Related]
67. Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Dandona P; Aljada A; Chaudhuri A; Mohanty P; Garg R Circulation; 2005 Mar; 111(11):1448-54. PubMed ID: 15781756 [No Abstract] [Full Text] [Related]
68. Pathophysiology of type 2 diabetes and its relationship to new therapeutic approaches. Bell D Diabetes Educ; 2000; 26 Suppl():4-7. PubMed ID: 11912815 [No Abstract] [Full Text] [Related]
69. Effect of doxazosin on insulin resistance in hypertensive patients with obesity. Ueshiba H; Miyachi Y Horm Metab Res; 2003 Sep; 35(9):532-6. PubMed ID: 14517769 [TBL] [Abstract][Full Text] [Related]
70. [Insulin resistance and arterial hypertension. Hyperinsulinism as a basic etiopathogenic factor in essential arterial hypertension and associated phenomena]. Hrnciar J; Hrnciarová M; Jakubíková K; Korónyi S Vnitr Lek; 1992 Sep; 38(9):868-78. PubMed ID: 1481385 [TBL] [Abstract][Full Text] [Related]
71. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. DeFronzo RA Neth J Med; 1997 May; 50(5):191-7. PubMed ID: 9175399 [TBL] [Abstract][Full Text] [Related]
72. Insulin resistance-associated cardiovascular disease: potential benefits of conjugated linoleic acid. Aminot-Gilchrist DV; Anderson HD Am J Clin Nutr; 2004 Jun; 79(6 Suppl):1159S-1163S. PubMed ID: 15159251 [TBL] [Abstract][Full Text] [Related]
73. Insulin resistance: an independent risk factor for cardiovascular disease? Balkau B; Eschwège E Diabetes Obes Metab; 1999 May; 1 Suppl 1():S23-31. PubMed ID: 11220285 [TBL] [Abstract][Full Text] [Related]
74. Adrenal incidentalomas: a manifestation of the metabolic syndrome? Reincke M; Fassnacht M; Väth S; Mora P; Allolio B Endocr Res; 1996 Nov; 22(4):757-61. PubMed ID: 8969938 [TBL] [Abstract][Full Text] [Related]
75. Common metabolic features of hypertension and type 2 diabetes. Usui I Hypertens Res; 2023 May; 46(5):1227-1233. PubMed ID: 36869145 [TBL] [Abstract][Full Text] [Related]
76. Hyperinsulinemia: a Cause of Obesity? Erion KA; Corkey BE Curr Obes Rep; 2017 Jun; 6(2):178-186. PubMed ID: 28466412 [TBL] [Abstract][Full Text] [Related]
77. Hyperinsulinemia: a link between obesity and hypertension? Hall JE Kidney Int; 1993 Jun; 43(6):1402-17. PubMed ID: 8315956 [No Abstract] [Full Text] [Related]
78. Vascular actions of insulin in health and disease. Shoemaker JK; Bonen A Can J Appl Physiol; 1995 Jun; 20(2):127-54. PubMed ID: 7640642 [TBL] [Abstract][Full Text] [Related]
79. Intracellular starvation in the insulin resistance syndrome and type II diabetes mellitus. Fournier AM Med Hypotheses; 1998 Aug; 51(2):95-9. PubMed ID: 9881813 [TBL] [Abstract][Full Text] [Related]